Ensuring Drug Security Forum

Medicine of the Future: Biomedical Technologies to Create New Drugs

05 Jun , 16:45–18:15
‘Ensuring Drug Security’ Russian Pharmaceutical Forum
Congress Centre, zone B, 2nd floor, conference hall B2

Medicine is constantly evolving and progressing, and one of the main components of this progress is biomedical technologies, which offer new possibilities for the creation of drugs that effectively combat various diseases. One of the key breakthroughs in modern medicine has been the development of personalized medicines. Biomarkers that are unique to individual patients or groups of patients enable physicians to administer the appropriate medications to achieve the best possible results. A key focus is the study of the human genome. Using modern DNA sequencing methods, scientists have managed to decipher the entire genome. This has made it possible to create individual medicines, taking into account a person’s genetic characteristics and predisposition to certain diseases. With the development of artificial intelligence, biomedical technologies are becoming even more advanced. Algorithms can analyse large volumes of data about diseases and clinical trial results, which helps scientists create new, more effective drugs. Biomedical technologies are contributing to the creation of new drugs. Personalized medicine, the use of stem cells, and advanced imaging techniques are providing more effective, precise, and minimally invasive treatments for various diseases. As biomedical technologies continue to advance, we can expect major advances in the development of medicines that will improve the health and well-being of people around the world. Which areas of high technology are the most promising and rapidly developing in global medical science? What innovative drugs for the treatment of socially significant diseases have been put into clinical practice today? What will help increase the availability of high-tech medical care to the population?

Moderator
Igor Borisevich, Deputy Head, Federal Medical-Biological Agency of the Russian Federation

Panellists
Badma Bashankaev, Deputy of the State Duma of the Federal Assembly of the Russian Federation; Member of the State Duma Committee on Health Protection
Konstantin Kotenko, Director, Academician B.V. Petrovsky Russian Scientific Center of Surgery
Sergei Lukyanov, Rector, N.I. Pirogov Russian National Research Medical University
Alexey Lundup, Director of the Scientific and Educational Resource Center for Cellular Technologies, Patrice Lumumba Peoples' Friendship University of Russia
Ekaterina Priezzheva, Deputy Minister of Industry and Trade of the Russian Federation
Sevastian Rabdano, Deputy Director for Development of New Medicines, Federal State Unitary Enterprise SPbNIIVS of the FMBA of Russia
Musa Khaitov, Director, National Research Center – Institute of Immunology of the FMBA of Russia

Broadcast